PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 574 of 732

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical (TSE:4528) Could Be 33% Undervalued As Opdivo And Pipeline Progress Build

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aribio Nears Phase 3 Results for Oral Alzheimer’s Drug... Mason Capital’s Investment Performance Becomes Visible

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

bpc 157 not fda approved The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York

news36live.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ExposeIQ JuryFit Helps Pharmaceutical Litigation Teams Transform Jury Selection Strategy with Human-Verified Insights

The Norfolk Daily NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Geared Power BioTech CEO, Gary Kellstrom, Jr. Featured on 'Going Beyond the Deal' Podcast with J. Michael Fischer, Jr.

EIN PresswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HC questions FDA push to invoke MCOCA in food safety cases across Maha

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis - PR Newswire APAC

PR Newswire AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Three Pharmaceutical Stocks to Consider Buying to Profit from a Weight-Loss Trend

Stock InvestorOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pangea Pharmaceuticals Advances Its Next Phase of Growth With an Expanding Commercial Portfolio

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medipost Doses First Patient in U.S. Phase 3 Trial for Knee Osteoarthritis Cell Therapy 'Cartistem'

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medipost's Cartistem Begins U.S. Phase 3, Doses First Patient

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The FDA Must Reinstate Safety Restrictions for Abortion Drug

vcy.orgOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Moderna filed Form 8-K

SEC EDGAROriginal source
🇺🇰Regulatorynice.org.ukTier 1 · Regulatory source

Novel life-saving liver procedure recommended, potentially enabling hundreds more transplants

NICEOriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

UCT study finds traces of banned toxic chemicals in children’s products

University of Cape TownOriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

Focusing on the future of constitutional democracy

University of Cape TownOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dih...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Collection; 60-Day Comment Request: Generic Clearance for the Collection of Customer Participation and Performance Management With NIH Programs, Products, and Services (Office of the Director)

In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide an opportunity...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Method of Detecting Circulating Cell-Free HPV 6 and 11 DNA in Patients Afflicted With Diseases Caused by Chronic HPV 6 or 11 Infection and Use Thereof

The National Cancer Institute (NCI) and Frederick National Laboratory for Cancer Research (FNLCR) se...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is seeki...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare Program; Announcement of the Advisory Panel on Hospital Outpatient Payment Meeting-August 24, 2026

This notice announces the virtual meeting of the Advisory Panel on Hospital Outpatient Payment (the...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Device User Fee Amendments; Public Meeting; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is announcing a hybrid public meeting titl...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Doxepin Hydrochloride

Official structured record identifier: 78cf65ff-43f9-4f5e-95dd-864acc89c02a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Sunitinib malate

Official structured record identifier: 7579e3d0-2de6-4239-a7a8-118ed92075f5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Bombee Honey Daily Glow Shield Sunscreen

Official structured record identifier: 56112dff-b091-7a56-e063-6294a90a77d3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Yuflyma

Official structured record identifier: 526d626f-8c9f-496c-b838-00a73bb36383.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Venlafaxine Hydrochloride

Official structured record identifier: 4e3053b9-cdec-4f4d-85ae-2e55cf1cc185.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB10 01

Official structured record identifier: 4a241d80-b9d2-ea93-e063-6294a90ab366.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB9 01

Official structured record identifier: 4a23f72b-4c33-a100-e063-6294a90ac632.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB8 01

Official structured record identifier: 4a23f728-a824-48a6-e063-6394a90acae7.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB6 01

Official structured record identifier: 4a23c619-e925-392c-e063-6394a90af5a4.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB7 01

Official structured record identifier: 4a23b531-ac53-f0df-e063-6294a90afcf9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB5 01

Official structured record identifier: 4a238f2d-efa9-01d1-e063-6294a90aae6f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB4 01

Official structured record identifier: 4a23653a-2481-bd15-e063-6394a90a7133.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB3 01

Official structured record identifier: 4a233350-729a-1e0c-e063-6394a90ad48c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB2 01

Official structured record identifier: 4a22c1c6-912a-7222-e063-6294a90a5406.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKIN-INFUSED FOUNDATION SPF 25- shade BB1 01

Official structured record identifier: 4a2105a7-6ae8-ed6e-e063-6394a90a3d07.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ziprasidone

Official structured record identifier: 48b54613-9b5f-4fcb-ba1f-22085ee0d8d1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Skin Protectant with Lanolin

Official structured record identifier: 46df52c8-0cbf-213e-e054-00144ff88e88.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Acetaminophen 250 mg Aspirin 250 mg Caffeine 65 mg

Official structured record identifier: 3590d417-272b-ae4d-e063-6394a90a5dc6.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Acetaminophen 500 Pyrilamine Maleate 15 and Caffeine 60

Official structured record identifier: 34eb8a9b-d0ee-13e8-e063-6294a90a2fef.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cyclobenzaprine Hydrochloride

Official structured record identifier: 34e57aff-dc4b-4631-9d57-31020244835d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Protex Balance antibacterial hand

Official structured record identifier: 29a0a75c-a8a1-4d11-87ae-6d2de4fa9518.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Isotretinoin

Official structured record identifier: 28948c32-a598-4bb5-bdb5-efbd87214d98.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Toms Wicked Fresh SLS-Free Peppermint (PWFT)

Official structured record identifier: 27278b02-c4fd-4092-a632-a14e442f5a95.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: COLGATE BAKING SODA AND PEROXIDE WHITENING OXYGEN BUBBLES FROSTY MINT

Official structured record identifier: 263fef13-347b-489b-987d-933a63dbc900.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 24e22e28-ec43-47e8-969f-788268ccba12.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ultra Violette Supreme Screen Broad Spectrum SPF 50

Official structured record identifier: 24389324-19db-7eb5-e063-6394a90ad7fb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: FAVLYXA

Official structured record identifier: 1daf714b-704c-4bcc-b6e0-6f0eb2bfe66b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Medline

Official structured record identifier: 1d731a44-f16e-c249-e063-6294a90a39b8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Hydrocortisone

Official structured record identifier: 1a27d8fa-4025-ed68-e063-6394a90a4f37.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: JANUVIA

Official structured record identifier: 194c3718-5eb5-4cf5-85d0-2bb1ed8293b8.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Degree

Official structured record identifier: 190bca3a-2f66-bee4-e063-6394a90ab2cf.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Procainamide Hydrochloride

Official structured record identifier: 17e47845-daad-434c-a784-6d3875b0d704.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Meprobamate

Official structured record identifier: 17d814e2-b277-4dce-8615-e7fd7cab773f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: LISINOPRIL

Official structured record identifier: 12d6fe7e-b5a2-4d49-9a06-a6150234d061.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: NITETIME COLD AND FLU

Official structured record identifier: 0e65c5d1-a18b-452c-9be6-8d44d34577e9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Natures Willow Balm Itch Relief Cream

Official structured record identifier: 0ce31b5d-4401-460c-e063-6394a90ab558.

openFDA Drug LabelsOriginal source